Skip to content
Search

Latest Stories

Submit Guest Post

Labour selects Krupesh Hirani for Brent and Harrow seat in upcoming London election

LABOUR MEMBERS have selected Krupesh Hirani as the candidate in Brent and Harrow for the London elections in May.

Hirani, an experienced local politician, will contest the seat after the sitting London assembly member Navin Shah announced he would be stepping down the role after 12 years.


Currently overseeing Brent’s year as the London Borough of Culture, Hirani already has a strong connection to Harrow having worked for the disability charity Aspire based within the grounds of the NHS Royal National Orthopaedic Hospital.

Hirani, a practising Hindu, has also volunteered at the Stanmore Hindu temple.

The selection is seen as a massive boost to Labour’s prospects of reconnecting with the Hindu community following the general decline in support for the Party amongst this key demographic in recent years.

Hirani said, “I’m delighted to be selected as Labour’s candidate in Brent and Harrow for the May 2020 London elections. It’s an honour to have the opportunity to represent my Party in the best part of the greatest city in the world; the area I have lived and worked in all of my life.

"As we move on to the elections in May, I look forward to campaigning and working hard for Brent and Harrow and retaining the seat for Labour as well as doing my bit to make sure we return Sadiq Khan as our Mayor of London.”

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cervical -cancer-hpv-vaccine

HPV is the most common sexually transmitted infection

Photo for representation: iStock

HPV vaccine reduces cervical cancer deaths to near zero, study finds

Highlights

  • No women aged 20–24 died from cervical cancer in England between 2020 and 2024
  • HPV vaccination is estimated to have prevented nearly 200 deaths among young women
  • Study provides first direct evidence linking HPV vaccination to reduced cervical cancer mortality
  • Vaccine introduced for girls in 2008 in the UK
  • Researchers say higher vaccination uptake is needed to protect future gains

THE HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed on Thursday (18).

Keep ReadingShow less